BDBM277128 7-[(1-methyl-1H-1,2,3-triazol-5-yl)methyl]- 4-(2,4,6-trifluorophenyl)-5,6,7,8-tetrahydro- 1,7-naphthyridine-2-carboxamide::US10072003, Example 2-21
SMILES: Cn1nncc1CN1CCc2c(C1)nc(cc2-c1c(F)cc(F)cc1F)C(N)=O
InChI Key: InChIKey=SETNCMGJXATHCN-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Metabotropic glutamate receptor 2 (Homo sapiens (Human)) | BDBM277128 (7-[(1-methyl-1H-1,2,3-triazol-5-yl)methyl]- 4-(2,4...) | PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 3.37E+4 | n/a | n/a | n/a | n/a | n/a | n/a |
TBA US Patent | Assay Description The utility of the compounds of the invention as antagonists of metabotropic glutamate receptor activity, in particular mGluR2 activity, may be demon... | US Patent US10072003 (2018) BindingDB Entry DOI: 10.7270/Q23R0VXK | |||||||||||
More data for this Ligand-Target Pair |